dr. mohler talk about, my good friend dr. mohler by the way. we worked together on a number of things, talk about five-year survival. when i'm teaching epidemiology and teaching screening, we don't use five-year survival is a good use of outcome. it is not an evaluation about, especially in prostate cancer where many of the people with screening would have never died if they had those autopsies. they actually artificially pushed the five-year survival rate up. this is best seen in the old studies of lung cancer. lung cancer screening with chest x-ray. by the way we have been here before. lung cancer screening was advocated in the united states from 1960 to about 1975. the otis brawley's of 1960 did a study. many people said no. it increases five-year survival rate. when those studies were done my favorite is the mayo clinic study. the death rate on the screened arm of the mayo clinic randomized chest x-ray study was 3.2 per thousand per year on the screen and 2.8 per thousand per year on the unscreened. keep in mind, survival was increased on t

dr. mohler talk about, my good friend dr. mohler by the way. we worked together on a number of things, talk about five-year survival. when i'm teaching epidemiology and teaching screening, we don't use five-year survival is a good use of outcome. it is not an evaluation about, especially in prostate cancer where many of the people with screening would have never died if they had those autopsies. they actually artificially pushed the five-year survival rate up. this is best seen in the old studies of lung cancer. lung cancer screening with chest x-ray. by the way we have been here before. lung cancer screening was advocated in the united states from 1960 to about 1975. the otis brawley's of 1960 did a study. many people said no. it increases five-year survival rate. when those studies were done my favorite is the mayo clinic study. the death rate on the screened arm of the mayo clinic randomized chest x-ray study was 3.2 per thousand per year on the screen and 2.8 per thousand per year on the unscreened. keep in mind, survival was increased on t

dr. mohler study and wonderful things a department of defense studies and it takes doctors to our practicing medicine to realize this is a problem the over diagnosis was put down by a number of positions in practice in the early 1990 90's with those of us who are seeing is a problem. know we have numerous studies the prostate prevention trials my favorite is the only steady to biopsy normal men been in the '60s over seven years could die ignite -- diagnose 13% and also shows that the psa mrs. just as many prostate cancer as unfounded of the 26% of men in the '60s who were diagnosed only 3% 12 dae. three out of the 26. that is the indication of the over treatment there was actually a vote in the integration committee earlier in the decade that said more money for the defense department ought to go to seeing how to take the money away from the studies of the biologic behavior of the prostate cancer so we lead to our emotions i am very emotional because i want men to get the right thing and i know i am hearing that men are not getting the right information. >> the gentleman's time is expired i